These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 968057)

  • 21. Postconceptional fertility control by prostaglandins.
    Toppozada M; Béguin F; Bygdeman M; Wide L; Wiqvist N
    Adv Biosci; 1973; 9():567-73. PubMed ID: 4805870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intra-amniotic administration of prostaglandin F 2 alpha, 12-methyl-prostaglandin F 2 alpha and hypertonic sodium chloride solution for induction of abortion in second-trimester pregnancy].
    Persianinov LS; Chernukha EA
    Zentralbl Gynakol; 1975; 97(19):1153-9. PubMed ID: 1189789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indian experience with a single long-acting vaginal suppository for the termination of pregnancies.
    Tejuja S; Choudhury SD; Manchanda PK; Malhotra U
    Contraception; 1979 Feb; 19(2):191-6. PubMed ID: 428234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of a 10 cm2, 0.5% 15-ME-PGF2alpha methyl ester intravaginal silastic device on abortion and plasma prostaglandin concentration.
    Lauersen NH; Wilson KH
    Prostaglandins; 1977 Apr; 13(4):755-62. PubMed ID: 857275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of silastic vaginal device containing (15S)-15 methyl prostaglandin F2 alpha methyl ester for early first trimester pregnancy termination.
    Robins J
    Prostaglandins; 1976; 12 Suppl():123-34. PubMed ID: 968061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early termination of pregnancy: a comparative study of intrauterine prostaglandin F2alpha and vacuum aspiration.
    Ragab MI; Edelman DA
    Prostaglandins; 1976 Feb; 11(2):261-73. PubMed ID: 1265295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of vaginal delivery systems containing 15[s]15-methyl PGF2alpha methyl ester.
    Spilman CH; Beuving DC; Forbes AD; Roseman TJ; Larion LJ
    Prostaglandins; 1976; 12 Suppl():1-16. PubMed ID: 968060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early pregnancy interruption by 15 (S) 15 methyl prostaglandin F2alpha methyl ester.
    Bygdeman M; Martin JN; Leader A; Lundström V; Ramadan M; Eneroth P; Gréen K
    Obstet Gynecol; 1976 Aug; 48(2):221-4. PubMed ID: 940655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induced abortion in the 8-9th week of pregnancy with vaginally administered 15-methyl PGF2alpha methyl ester.
    Leader A; Bygdeman M; Eneroth P; Lundström V; Martin JN
    Prostaglandins; 1976 Oct; 12(4):631-7. PubMed ID: 973008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitation of uterine activity after vaginal administration of prostaglandins.
    Henzl MR; Arvealo TN; Noriega L; Aznar R; Ortega E; Segre E
    Adv Biosci; 1973; 9():767-72. PubMed ID: 4805889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Midtrimester abortion induced by single intra-amniotic instillation of two dose schedules of 15(S)-15-methyl-prostaglandin F2alpha.
    Lauersen NH; Wilson KH
    Prostaglandins; 1975 Apr; 9(4):617-25. PubMed ID: 1153812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose vaginal 15 methyl prostaglandin F2 alpha for cervical dilatation prior to vacuum curettage abortion.
    Niloff JM; Stubblefield PG
    Am J Obstet Gynecol; 1982 Mar; 142(5):596-7. PubMed ID: 7036748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a vaginal suppository suitable for single administration for interruption of second trimester pregnancy.
    Bygdeman M; Ganguli A; Kinoshita K; Lundström V; Green K; Bergström S
    Contraception; 1977 Feb; 15(2):129-41. PubMed ID: 837687
    [No Abstract]   [Full Text] [Related]  

  • 34. Outpatient postconceptional fertility control with vaginally administered 15(S) 15-methyl-PGF2alpha-methyl ester.
    Bygdeman M; Martin JN; Eneroth P; Leader A; Lundström V
    Am J Obstet Gynecol; 1976 Mar; 124(5):495-8. PubMed ID: 1258906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The induction of abortion and the priming of the cervix with prostaglandin F2 alpha and prostaglandin E2 by intra-amniotic, extra-amniotic and intra-cervical application (author's transl)].
    Schmidt W; Widmaier G; Ditz S; Kubli F
    Geburtshilfe Frauenheilkd; 1982 Feb; 42(2):118-22. PubMed ID: 6917804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Midtrimester abortion induced by serial intravaginal administration of prostaglandin E2 suppositories in conjunction with a contraceptive diaphragm.
    Lauersen NH; Wilson KH
    Prostaglandins; 1975 Jul; 10(1):139-50. PubMed ID: 1153798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postconception menses induction using prostaglandin vaginal suppositories.
    Foster HW; Smith M; McGruder CE; Richard F; McIntyre J
    Obstet Gynecol; 1985 May; 65(5):682-5. PubMed ID: 3982746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interruption of first trimester pregnancy by prostaglandins.
    Bygdeman M; Green K; Lundström V
    Int J Gynaecol Obstet; 1977; 15(1):69-72. PubMed ID: 923898
    [No Abstract]   [Full Text] [Related]  

  • 39. Induction of abortion with 15(S)-15-methyl PGF2alpha (Tham) vaginal suppositories.
    Vengadasalam D; Lean TH; Edelman DA
    Int J Gynaecol Obstet; 1977; 15(1):93-5. PubMed ID: 923901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary trials of vaginal silastic devices containing (15s)-15 methyl prostaglandin f2 alpha methyl ester for the induction of menses and for pregnancy termination summary of brook lodge workshop (January 29, 1976).
    Southern EM
    Prostaglandins; 1976; 12 Suppl():147-52. PubMed ID: 788056
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.